LEADS BIOLABS-B(09887) has been granted approval for full circulation of H shares by the Hong Kong Stock Exchange.
Vitasoy International Holdings Limited (09887) announced that the company has received approval from the Stock Exchange of Hong Kong on May 14, 2026 to list and trade approximately 44.39 million H shares.
LEADS BIOLABS-B (09887) announced that the company has received approval from the Hong Kong Stock Exchange on May 14, 2026 to list and trade approximately 44.39 million H shares.
Related Articles
NEWTREND GROUP (02573): Zhang Qian appointed as independent non-executive director.
C CARBONNEUTRAL (01372) issues 64.29 million stock options.
YEEBO (INT'L H) (00259) issued 1.861 million share options.
NEWTREND GROUP (02573): Zhang Qian appointed as independent non-executive director.
C CARBONNEUTRAL (01372) issues 64.29 million stock options.
YEEBO (INT'L H) (00259) issued 1.861 million share options.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
